New long‑term results from the RUBY clinical trial show that adding immunotherapy (dostarlimab) to chemotherapy may help some ...

ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby® XL System, the longest, largest and ...

Penumbra, Inc. PEN recently launched the Ruby XL System, the longest, largest and softest coil in the market, followed by its Food and Drug Administration (FDA) clearance. The Ruby XL System is ...